SCHEMBL6487930

SCHEMBL6487930

NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CC(O)C(O)C1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.82
PDGFRB P09619 9/20 0.82
FLT1 P17948 6/20 0.82
PLK4 O00444 1/20 0.82
AURKA O14965 1/20 0.82
EPHB6 O15197 1/20 0.82
RIPK2 O43353 1/20 0.82
STK10 O94804 1/20 0.82
MAP4K4 O95819 1/20 0.82
ABL1 P00519 1/20 0.82
EGFR P00533 1/20 0.82
INSR P06213 1/20 0.82
LCK P06239 1/20 0.82
FYN P06241 1/20 0.82
YES1 P07947 1/20 0.82
LYN P07948 1/20 0.82
RET P07949 1/20 0.82
MET P08581 1/20 0.82
ROS1 P08922 1/20 0.82
BCR P11274 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3091163 0.92 KDR (0.70) KDRPDGFRBFLT1PLK4AURKA
SCHEMBL377827 0.92 KDR (0.70) KDRPDGFRBFLT1PLK4AURKA
Osi-632 SCHEMBL187261 0.90 KDR (1.00) KDRPDGFRBFLT1PLK4AURKA
Osi-632 SCHEMBL438781 0.90 KDR (0.98) KDRPDGFRBFLT1PLK4AURKA
Osi-632 SCHEMBL5705524 0.90 KDR (0.98) KDRPDGFRBFLT1PLK4AURKA
Osi-632 SCHEMBL5705534 0.89 KDR (0.94) KDRPDGFRBFLT1PLK4AURKA
SCHEMBL6484366 0.89 KDR (0.77) KDRPDGFRBFLT1PLK4AURKA
SCHEMBL19588989 0.89 KDR (0.79) KDRPDGFRBFLT1PLK4AURKA
SCHEMBL3085161 0.88 KDR (0.65) KDRPDGFRBFLT1PLK4AURKA
SCHEMBL6478624 0.88 KDR (0.74) KDRPDGFRBFLT1PLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005110406-A2 PHENYL DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2005-11-24 WO claimed
US-20050256177-A1 Phenyl derivatives for the treatment of abnormal cell growth PFIZER INC 2005-11-17 US claimed
WO-2005110406-A2 PHENYL DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2005-11-24 WO disclosed
US-20050256177-A1 Phenyl derivatives for the treatment of abnormal cell growth PFIZER INC 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256177-A1 Phenyl derivatives for the treatment of abnormal cell growth CCND3, CDC25C, CCNA1 KDR 2216/4885PDGFRB 1592/4885FLT1 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.